AstraZeneca-Merck’s Lynparza wins EU approval for pancreatic cancer The approval was based on results from a late-stage trial in which Lynparza nearly doubled the lifespan of patients AstraZeneca…
Oxford COVID-19 vaccine developers encouraged by immune response but cautious on timeframe 8,000 volunteers had been enrolled for the Phase III of its trial into the vaccine, AZD1222, which was licensed to AstraZeneca…
US FDA comes out with guidance for COVID-19 vaccine approval More than 100 vaccines are being tested worldwide against the virus The US Food and Drug Administration released…
Biocartis enters into collaboration agreement with AstraZeneca and initiates EGFR Liquid Biopsy… The announcement marks a broadening of the existing partnership between Biocartis and AstraZeneca that focussed on demonstrating…
Sweden, AIIMS Delhi and AIIMS Jodhpur launch India-Sweden Healthcare Innovation Centre in India The collaboration will help to strengthen the healthcare delivery system by an outcome and result based approach The Swedish…
NASSCOM, AstraZeneca strengths collaboration towards driving digital healthcare Flagship health tech event 'Re-defining the Healthcare Landscape - The Digital Shift,' held in Bengaluru AstraZeneca and…
AstraZeneca, Nasscom to set up accelerator programme in healthcare The partnership between the two organisations will incubate start-ups in bringing innovative and frugal solutions that can help in…